​

Coya Therapeutics Ownership | Who Owns Coya Therapeutics?

OverviewForecastRevenueFinancialsChart

Coya Therapeutics Ownership Summary

Coya Therapeutics is owned by 28.36% institutional investors, 5.69% insiders, and 65.95% retail investors. Dme capital management, lp is the largest institutional shareholder, holding 9.84% of COYA shares.

COYA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCoya Therapeutics28.36%5.69%65.95%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Dme capital management, lp1.65M9.84%$9.38M
Aigh capital management1.11M6.61%$6.30M
Vanguard group836.39K5.00%$4.77M
Cm management300.00K1.79%$1.71B
Geode capital management156.84K0.94%$894.28K
Dauntless investment group153.02K0.91%$872.22K
Blackrock funding, inc. /de69.96K0.42%$398.76K
State street48.10K0.29%$274.17K
Marshall wace, llp41.83K0.25%$238.40K
Prelude capital management35.77K0.21%$203.89K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigh capital management1.11M1.78%$6.30M
Cm management300.00K1.43%$1.71B
Dauntless investment group153.02K0.55%$872.22K
Dme capital management, lp1.65M0.37%$9.38M
Prosperity wealth management23.80K0.05%$135.66K
Prelude capital management35.77K0.02%$203.89K
Ghp investment advisors26.17K0.01%$149.18K
State of wyoming3.26K0.00%$18.58K
Quadrature capital19.89K0.00%$113.79K
Renaissance34.80K0.00%$198.36K

Top Buyers

HolderShares% AssetsChange
Dauntless investment group153.02K0.55%101.93K
Cm management300.00K1.43%100.00K
Marshall wace, llp41.83K0.00%41.83K
Royal bank of canada35.38K-22.00K
Renaissance34.80K0.00%20.80K

Top Sellers

HolderShares% AssetsChange
Jane street group---26.54K
Atom investors lp---20.08K
Northern trust32.32K--7.05K
Vanguard group836.39K0.00%-4.08K
Key financial---2.00K

New Positions

HolderShares% AssetsChangeValue
Marshall wace, llp41.83K0.00%41.83K$238.40K
Quadrature capital19.89K0.00%19.89K$113.79K
Jpmorgan chase5.00K-5.00K$28.50K
Allworth financial lp1.00K-1.00K$5.75K
Rockefeller capital management500.00-500.00$2.85K

Sold Out

HolderChange
Raymond james financial-1.98K
Key financial-2.00K
Atom investors lp-20.08K
Jane street group-26.54K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202533-4,743,2295.76%283.94%16-5.88%7-12.50%
Jun 30, 20253326.92%4,486,560-3.78%263.45%176.25%775.00%
Mar 31, 202526-4,662,5914.94%273.28%16-15.79%4-
Dec 31, 20242636.84%4,443,11234.02%296.15%19216.67%4-33.33%
Sep 30, 202419-3,315,1611.43%214.54%6-33.33%6-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 14, 2024SNYDER DAVID S Chief Financial OfficerBuy$12.93K
Nov 13, 2024Swaminathan Arun Chief Executive OfficerBuy$36.80K
Nov 11, 2024Grossman Fred Chief Medical OfficerBuy$19.97K
Nov 11, 2024Swaminathan Arun Chief Executive OfficerBuy$36.69K
Aug 22, 2023Lee Ann-Buy$3.62K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q1--
2024 Q44-
2024 Q3--
2024 Q2--

COYA Ownership FAQ

Who Owns Coya Therapeutics?

Coya Therapeutics shareholders are primarily institutional investors at 28.36%, followed by 5.69% insiders and 65.95% retail investors. The average institutional ownership in Coya Therapeutics's industry, Biotech Stocks , is 45.24%, which Coya Therapeutics falls below.

Who owns the most shares of Coya Therapeutics?

Coya Therapeutics’s largest shareholders are Dme capital management, lp (1.65M shares, 9.84%), Aigh capital management (1.11M shares, 6.61%), and Vanguard group (836.39K shares, 5.00%). Together, they hold 21.46% of Coya Therapeutics’s total shares outstanding.

Does Blackrock own Coya Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Coya Therapeutics.

Who is Coya Therapeutics’s biggest shareholder by percentage of total assets invested?

Aigh capital management is Coya Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.78% of its assets in 1.11M Coya Therapeutics shares, valued at 6.3M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools